These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9048621)

  • 1. The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease.
    Ritchie CK; Andrews LR; Thomas KG; Tindall DJ; Fitzpatrick LA
    Endocrinology; 1997 Mar; 138(3):1145-50. PubMed ID: 9048621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.
    Lee HL; Pienta KJ; Kim WJ; Cooper CR
    Int J Oncol; 2003 Apr; 22(4):921-6. PubMed ID: 12632088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
    Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
    Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
    Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
    Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation.
    Lind M
    Acta Orthop Scand Suppl; 1998 Oct; 283():2-37. PubMed ID: 9856074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
    Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
    Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotaxis of human osteoblasts. Effects of osteotropic growth factors.
    Lind M; Deleuran B; Thestrup-Pedersen K; Søballe K; Eriksen EF; Bünger C
    APMIS; 1995 Feb; 103(2):140-6. PubMed ID: 7748538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3-E1 osteoblastic cells.
    Bhattacharyya RS; Stern PH
    J Cell Biochem; 2003 Dec; 90(5):925-37. PubMed ID: 14624452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of endothelin 1 and its precursor by IL-1beta, TNF-alpha, and TGF-beta in the PC3 human prostate cancer cell line.
    Le Brun G; Aubin P; Soliman H; Ropiquet F; Villette JM; Berthon P; Créminon C; Cussenot O; Fiet J
    Cytokine; 1999 Feb; 11(2):157-62. PubMed ID: 10089138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
    Yeh LC; Adamo ML; Olson MS; Lee JC
    Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-beta isoforms.
    Makhijani NS; Bischoff DS; Yamaguchi DT
    J Cell Physiol; 2005 Jan; 202(1):304-13. PubMed ID: 15389595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis.
    Ritchie CK; Thomas KG; Andrews LR; Tindall DJ; Fitzpatrick LA
    Prostate; 1997 Feb; 30(3):183-7. PubMed ID: 9122043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.
    Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ
    J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone.
    Rajan R; Vanderslice R; Kapur S; Lynch J; Thompson R; Djakiew D
    Prostate; 1996 Jan; 28(1):1-9. PubMed ID: 8545275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
    Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
    Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid.
    Marcelli M; Haidacher SJ; Plymate SR; Birnbaum RS
    Endocrinology; 1995 Mar; 136(3):1040-8. PubMed ID: 7532576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.